Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,728
Total Claims
$1.3M
Drug Cost
907
Beneficiaries
$1,463
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-92%
Opioid rate vs peers
0.2% vs 2.6% avg
+37%
Cost per patient vs peers
$1,463 vs $1,068 avg
+27%
Brand preference vs peers
11.4% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
21
Opioid Claims
$68
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,212 claims · $1.1M
Generic: 9,402 claims · $197K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 134 | $233K |
| Apixaban | 91 | $128K |
| Empagliflozin | 77 | $127K |
| Fluticasone/Umeclidin/Vilanter | 75 | $110K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $61K |
| Dulaglutide | 27 | $46K |
| Rivaroxaban | 26 | $43K |
| Empagliflozin/Linagliptin | 31 | $38K |
| Denosumab | 19 | $32K |
| Mirabegron | 29 | $31K |
| Tiotropium Bromide | 28 | $22K |
| Varenicline Tartrate | 26 | $19K |
| Fluticasone Propion/Salmeterol | 49 | $17K |
| Liraglutide | 17 | $15K |
| Linaclotide | 11 | $14K |
Prescribing Profile
Patient Profile
76
Avg Age
54%
Female
1.60
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About